About this episode
What if your diagnosis of type 2 diabetes, high blood pressure, or fatty liver wasn’t a permanent sentence, but a condition that could improve or even reverse through targeted intervention?In this episode of the Metabolic Mind podcast, Dr. Bret Scher sits down with Dr. Adam Wolfberg, Chief Medical Officer at Virta Health, to explore groundbreaking data that challenges the conventional approach to managing chronic metabolic disease. They dive into Virta’s latest annual report, which highlights powerful clinical and economic outcomes that could reshape the future of medicine.In this interview, you'll learn:Why "reversal" is replacing "management" in the metabolic care conversationHow Virta’s data shows a 56% reduced risk of heart attack, stroke, or deathThe role of carbohydrate-restricted and ketogenic nutrition in improving metabolic healthHow patients across socioeconomic backgrounds, including those in food deserts, are seeing resultsWhere medications like GLP-1 fit into a lifestyle-first modelWhat this model means for healthcare costs, medication reduction, and long-term patient outcomesVirta’s annual report highlights how a shift toward value-based care and personalized, nutrition-driven approaches can drastically improve patient outcomes.Check it out here: https://www.virtahealth.com/reversal-report#MetabolicMind #KetogenicTherapy #MetabolicHealth #FoodAsMedicineExpert Featured:Dr. Adam WolfbergChief Medical Officer at Virta Healthwww.Vitrahealth.comLinkedIn.com/in/adamwolfbergResources Mentioned:Virta’s 2025 Annual Report on Metabolic Disease Reversalhttps://www.virtahealth.com/reversal-reportHealthcare utilization and cost impact of telehealth-delivered nutrition therapy for type 2 diabetes and obesity: a retrospective claims-based studyhttps://doi.org/10.1101/2025.11.09.25339829Real-World Cardiovascular Outcomes with a Carbohydrate-Reduced Telemedicine Interventionhttps://doi.org/10.1101/2025.10.27.25338916Reduced Onset of MASLD, MASH, and Advanced Liver Disease in patients who received Individuali
